⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BBIO News
BridgeBio Pharma, Inc. Common Stock
BridgeBio to Participate in the J.P. Morgan Healthcare Conference
globenewswire.com
BBIO
BridgeBio to Host Achondroplasia Investor Webinar on Friday, January 9th at 8:00 am ET
globenewswire.com
BBIO
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BBIO
Buffalo Biodiesel Advances Facility Modernization With Completion of Key NYSDEC Compliance Milestones
prnewswire.com
BBIO
John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scientific Conference
globenewswire.com
AMGN
REGN
GILD
BMY
AZN
NVS
ARGX
BIIB
BBIO
SRRK
Comanche Biopharma Appoints Richard Colvin, MD, PhD as Global Head of R&D and John McHutchison, AO, MD as Chairman and Director of Comanche Biopharma Australia
globenewswire.com
CBIO
BBIO
NVS
TUNE
VELI
ASMB
GILD
Intratumoral Cancer Therapies Market to Reach USD 630.7 Million by 2033 as Next-Generation Localized Immunotherapies Transform Solid Tumor Treatment
prnewswire.com
PFE
BMY
BBIO
BSX
BridgeBio to Participate in December Investor Conferences
globenewswire.com
BBIO
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BBIO
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
globenewswire.com
BBIO